Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.64 USD
Change Today +0.0199 / 3.21%
Volume 32.6K
OVIT On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tamas Bakos Ph.D.

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

52--

Background*

Tamas Bakos, Ph.D., served as Director of Preclinical Research of OncoVista Innovative Therapies, Inc. (formerly Oncovista, Inc.) since. Dr. Bakos served as Director of Preclinical Research at Aviation Upgrade Technologies Inc. since January 2005. He has 12+ years of preclincal drug development experience. Prior to joining Aviation Upgrade Technologies, Dr. Bakos was a Research Chemist at Lipitek International, Inc. from March 1995 to January 2005. Dr. Bakos received ...

Read Full Background

Corporate Headquarters*

14785 Omicron Drive
San Antonio, Texas 78245

United States

Phone: 210-677-6000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OVIT:US $0.64 USD +0.0199

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOVISTA INNOVATIVE THERAPI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.